medcura

3 known investors

Medcura develops biopolymer-based hemostatic products that stop surgical bleeding through mechanical means without swelling, designed for surgical procedures including spine surgery. The company targets surgeons, hospitals, and healthcare payers with cost-effective bleeding management solutions.